Gammex ACR 464 Extension Plates

The Gammex CT (computed tomography) Perfusion Phantom is designed to mimic a perfusion study where traceable material is monitored as it travels through brain tissue. Software that is proprietary to the CT scanner is then used to determine blood flow rate curves and to compare them to known normals. This provides a reference baseline.

Gammex CT Perfusion Phantom

New research describes a method, tested in rats, that may someday allow healthcare providers to quickly scan the entire body for a blood clot. The research was presented at the 250th National Meeting & Exposition of the American Chemical Society (ACS), Aug. 16-20, in Boston.

In the wake of a new report from the Institute of Medicine (IOM) on improving diagnostic capability in healthcare, the American College of Radiology (ACR) praised the document, of which it is a sponsor. The ACR commended IOM on its thorough analysis of the complex process of diagnosis and its recommendations for improvement, and voiced its support for collaborative, patient-centered approaches to reduce diagnostic errors.

The World Molecular Imaging Society (WMIS) presented the first annual Commercial Innovation of the Year Award at the 2015 World Molecular Imaging Congress (WMIC) to Frederik Beekman, CEO/CSO, MILabs for his work developing G-SPECT.

ONC, Federal Health IT Strategic Plan 2015-2020, information technology, healthcare

The U.S. Department of Health and Human Services’ Office of the National Coordinator for Health Information Technology (ONC), in collaboration with over 35 federal partners, released the updated Federal Health IT Strategic Plan 2015–2020 (Plan) September 21.
Frost & Sullivan, top medical technologies, growth, healthcare

Frost & Sullivan released its list of top medical technologies for 2015, featuring an array of sophisticated inventions in medical devices, diagnostics and imaging. These innovations have given birth to less expensive and flexible healthcare solutions; playing a critical role in managing the increasing frequency of chronic diseases around the globe.
Michael Cross, BioZorb, breast cancer, hypofractionated radiation therapy

Breast cancer research conducted by two Fayetteville, Arkansas, medical groups highlights their success in pioneering use of an absorbable, three-dimensional marker used during treatment for breast cancer. Their cost analysis, to be presented at an international breast cancer conference this week, showed that by helping to shorten the course of radiation treatments, the surgical marker contributed to a 25 percent cost savings per patient.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now